The states with the highest rates of HIV diagnoses in 2022 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were Texas, California, and Florida. In Texas, there were around 4,896 people diagnosed with HIV. HIV/AIDS diagnoses In 2022, there were an estimated 38,043 new HIV diagnoses in the United States, a slight increase compared to the year before. Men account for the majority of these new diagnoses. There are currently around 1.2 million people living with HIV in the United States. Deaths from HIV The death rate from HIV has decreased significantly over the past few decades. In 2023, there were only 1.3 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.2 per 100,000 population in 2022, compared to just three deaths per 100,000 among the white population.

As of 2024, South Africa was the country with the highest number of people living with HIV in Africa. At that time, around 7.8 million people in South Africa were HIV positive. In Mozambique, the country with the second-highest number of HIV-positive people in Africa, around 2.5 million people were living with HIV. Which country in Africa has the highest prevalence of HIV? Although South Africa has the highest total number of people living with HIV in Africa, it does not have the highest prevalence of HIV on the continent. Eswatini currently has the highest prevalence of HIV in Africa and worldwide, with almost 26 percent of the population living with HIV. South Africa has the third-highest prevalence, with around 18 percent of the population HIV positive. Eswatini also has the highest rate of new HIV infections per 1,000 population worldwide, followed by South Africa and Mozambique. However, South Africa had the highest total number of new HIV infections in 2024, with around 170,000 people newly infected with HIV that year. Deaths from HIV in Africa Thanks to advances in treatment and awareness, HIV/AIDS no longer contributes to a significant amount of death in many countries. However, the disease is still the eighth leading cause of death in Africa, accounting for around 4.6 percent of all deaths. In 2024, South Africa and Mozambique were the countries with the highest number of AIDS-related deaths worldwide, with 53,000 and 44,000 such deaths, respectively. Although not every country in the leading 25 for AIDS-related deaths is found in Africa, African countries account for the majority of countries on the list. Fortunately, HIV treatment has become more accessible in Africa over the years, and now up to 94 percent of people living with HIV in Eswatini are receiving antiretroviral therapy (ART). Access to ART does vary from country to country, however, with around 81 percent of people who are HIV positive in South Africa receiving ART and only 34 percent in the Congo.

Data Dictionary JANUARY, 2020 Gender Inequality & HIV/AIDS

Country The country the data corresponds to.The data is a subset of UNICEF’s ‘Key HIV epidemiology indicators for children and adolescents aged 10-19, 1990-2019.’This UNICEF data is sourced from UNAIDS 2020 estimates, which provide ‘modeled estimates using the best available epidemiological and programmatic data to track the HIV epidemic’. Modeled estimates are used because counting the true numbers would require regularly testing entire populations for HIV, and investigating all deaths, which is ‘logistically impossible and ethically problematic.’ For more information on the methodology behind these estimates, see the full UNAIDS 2020 report.

UNICEF Region The region the country belongs to - this dataset includes countries from Eastern & Southern Africa, and West & Central Africa.

Year The year the estimates corresponds to.

Sex Whether the estimates refer to men or women.

Age The age group that the estimates refer to - this dataset contains only estimates for adolescent women and men between the ages of 10-19.

Estimated incidence rate of new HIV infection per 1000 uninfected population The estimated number of new HIV infections, for every 1000 uninfected people in the relevant group. Note - some fields were displayed as ‘<0.01’ in the original data, however these have been rounded up to 0.01 in order to make the field numeric.

Estimated number of annual AIDS related deaths The estimated number of annual AIDS related deaths in the relevant group, to the nearest 100. Note - in the original data, values below 500 were split into the following groups; <500, <200, and <100. To make the field numeric, these have been rounded to 500, 200, and 100 respectively.

Estimated number of annual new HIV infections The estimated number of new annual HIV infections in the relevant group. Note - in the original data, values below 500 were split into the following groups; <500, <200, and <100. To make the field numeric, these have been rounded to 500, 200, and 100 respectively.

The estimated number of people living with HIV in the relevant group. Note - in the original data, values below 500 were split into the following groups; <500, <200, and <100. To make the field numeric, these have been rounded to 500, 200, and 100 respectively.

Estimated rate of annual AIDS related deaths per 100,000 population The estimated number of annual AIDS related deaths, for every 100,000 people in the relevant group. Note - some fields were displayed as ‘<0.01’ in the original data, however these have been rounded up to 0.01 in order to make the field numeric.

Data Source: UNICEF ‘Key HIV epidemiology indicators for children and adolescents aged 10-19, 1990-2019

In 2022, the states with the highest number of HIV diagnoses were Texas, California, and Florida. That year, there were a total of around 37,601 HIV diagnoses in the United States. Of these, 4,896 were diagnosed in Texas. HIV infections have been decreasing globally for many years. In the year 2000, there were 2.8 million new infections worldwide, but this number had decreased to around 1.3 million new infections by 2023. The number of people living with HIV remains fairly steady, but the number of those that have died due to AIDS has reached some of its lowest peaks in a decade. Currently, there is no functional cure for HIV or AIDS, but improvements in therapies and treatments have enabled those living with HIV to have a much improved quality of life.

Context

The New York City Department of Health and Mental Hygiene publishes mid-year and annual HIV surveillance reports each year. This dataset is taken from these reports and includes data gathered from 2011 to June 30, 2016.

Content

This dataset includes HIV infections and AIDS diagnoses, viral suppression in persons living with diagnosed HIV infection (PLWDHI), deaths of those with diagnosed HIV infection, and other statistics from 2011 to 2015 in New York City boroughs.

Purpose

The data contained here shows trends in age, gender, and geographic demographics over time for HIV infections in NYC, and this can be used to visualize the prevalence of the virus in the city.

Acknowledgement

This data was pulled from NYC's OpenData at https://data.cityofnewyork.us/Health/DOHMH-HIV-AIDS-Annual-Report/fju2-rdad .

People aged 15 to 59 years seen at HIV services in the UK, expressed as a rate per 1,000 population.Data is presented by area of residence, and exclude people diagnosed with HIV in England who are resident in Wales, Scotland, Northern Ireland or abroad.RationaleThe geographical distribution of people seen for HIV care and treatment is not uniform across or within regions in England. Knowledge of local diagnosed HIV prevalence and identification of local risk groups can be used to help direct resources for HIV prevention and treatment.In 2008, http://www.bhiva.org/HIV-testing-guidelines.aspx recommended that Local Authority and NHS bodies consider implementing routine HIV testing for all general medical admissions as well as new registrants in primary care where the diagnosed HIV prevalence exceeds 2 in 1,000 population aged 15 to 59 years.In 2017, guidelines were updated by https://www.nice.org.uk/guidance/NG60 which is co-badged with Public Health England. This guidance continues to define high HIV prevalence local authorities as those with a diagnosed HIV prevalence of between 2 and 5 per 1,000 and extremely high prevalence local authorities as those with a diagnosed HIV prevalence of 5 or more per 1,000 people aged 15 to 59 years.When this is applied to national late HIV diagnosis data, it shows that two-thirds of late HIV diagnoses occur in high-prevalence and extremely-high-prevalence local authorities. This means that if this recommendation is successfully applied in high and extremely-high-prevalence areas, it could potentially affect two-thirds of late diagnoses nationally.Local authorities should find out their diagnosed prevalence published in UKHSA's http://fingertips.phe.org.uk/profile/sexualhealth , as well as that of surrounding areas and adapt their strategy for HIV testing using the national guidelines.Commissioners can use these data to plan and ensure access to comprehensive and specialist local HIV care and treatment for HIV diagnosed individuals according to the http://www.medfash.org.uk/uploads/files/p17abl6hvc4p71ovpkr81ugsh60v.pdf and http://www.bhiva.org/monitoring-guidelines.aspx .Definition of numeratorThe number of people (aged 15 to 59 years) living with a diagnosed HIV infection and accessing HIV care at an NHS service in the UK and who are resident in England.Definition of denominatorResident population aged 15 to 59.The denominators for 2011 to 2023 are taken from the respective 2011 to 2023 Office for National Statistics (ONS) revised population estimates from the 2021 Census.Further details on the ONS census are available from the https://www.ons.gov.uk/census .CaveatsData is presented by geographical area of residence. Where data on residence were unavailable, residence have been assigned to the local health area of care.Every effort is made to ensure accuracy and completeness of the data, including web-based reporting with integrated checks on data quality. The overall data quality is high as the dataset is used for commissioning purposes and for the national allocation of funding. However, responsibility for the accuracy and completeness of data lies with the reporting service.Data is as reported but rely on ‘record linkage’ to integrate data and ‘de-duplication’ to prevent double counting of the same individual. The data may not be representative in areas where residence information is not known for a significant proportion of people accessing HIV care.Data supplied for previous years are updated on an annual basis due to clinic or laboratory resubmissions and improvements to data cleaning. Data may therefore differ from previous publications.Values are benchmarked against set thresholds and categorised into the following groups: <2 (low), 2 to 5 (high) and≥5 (extremely high). These have been determined by developments in national testing guidelines.The data reported in 2020 and 2021 is impacted by the reconfiguration of sexual health services during the national response to COVID-19.

United States US: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.110 Ratio in 2019. This stayed constant from the previous number of 0.110 Ratio for 2018. United States US: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.120 Ratio from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 0.130 Ratio in 2012 and a record low of 0.110 Ratio in 2019. United States US: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

In 2024, in South Africa, there were around 3.1 HIV newly infected persons per every 1,000 inhabitants. This statistic depicts the countries with the highest incidence rates of new HIV infections worldwide as of 2024.

1CI, Confidence Interval.2Incidence estimate not calculated due to incomplete data.

Series Name: Number of new HIV infections per 1 000 uninfected population by sex and age (per 1 000 uninfected population)Series Code: SH_HIV_INCDRelease Version: 2021.Q2.G.03 This dataset is the part of the Global SDG Indicator Database compiled through the UN System in preparation for the Secretary-General's annual report on Progress towards the Sustainable Development Goals.Indicator 3.3.1: Number of new HIV infections per 1,000 uninfected population, by sex, age and key populationsTarget 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseasesGoal 3: Ensure healthy lives and promote well-being for all at all agesFor more information on the compilation methodology of this dataset, see https://unstats.un.org/sdgs/metadata/

Laos LA: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.140 Ratio in 2022. This stayed constant from the previous number of 0.140 Ratio for 2021. Laos LA: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.150 Ratio from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.170 Ratio in 2013 and a record low of 0.010 Ratio in 1993. Laos LA: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Laos – Table LA.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

Data Series: Number of new HIV infections per 1,000 uninfected population, by sex and age Indicator: III.8 - Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations Source year: 2023 This dataset is part of the Minimum Gender Dataset compiled by the United Nations Statistics Division. Domain: Health and related services

BackgroundNew York City (NYC) remains an epicenter of the HIV epidemic in the United States. Given the variety of evidence-based HIV prevention strategies available and the significant resources required to implement each of them, comparative studies are needed to identify how to maximize the number of HIV cases prevented most economically.MethodsA new model of HIV disease transmission was developed integrating information from a previously validated micro-simulation HIV disease progression model. Specification and parameterization of the model and its inputs, including the intervention portfolio, intervention effects and costs were conducted through a collaborative process between the academic modeling team and the NYC Department of Health and Mental Hygiene. The model projects the impact of different prevention strategies, or portfolios of prevention strategies, on the HIV epidemic in NYC.ResultsTen unique interventions were able to provide a prevention benefit at an annual program cost of less than $360,000, the threshold for consideration as a cost-saving intervention (because of offsets by future HIV treatment costs averted). An optimized portfolio of these specific interventions could result in up to a 34% reduction in new HIV infections over the next 20 years. The cost-per-infection averted of the portfolio was estimated to be $106,378; the total cost was in excess of $2 billion (over the 20 year period, or approximately $100 million per year, on average). The cost-savings of prevented infections was estimated at more than $5 billion (or approximately $250 million per year, on average).ConclusionsOptimal implementation of a portfolio of evidence-based interventions can have a substantial, favorable impact on the ongoing HIV epidemic in NYC and provide future cost-saving despite significant initial costs.

Forecast: Number of New HIV Infections in the US 2023 - 2027 Discover more data with ReportLinker!

The average for 2022 based on 135 countries was 1.66 percent. The highest value was in Swaziland: 25.9 percent and the lowest value was in Afghanistan: 0.1 percent. The indicator is available from 1990 to 2022. Below is a chart for all countries where data are available.

United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.130 Ratio in 2020. This records an increase from the previous number of 0.120 Ratio for 2019. United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.020 Ratio from Dec 1990 (Median) to 2020, with 31 observations. The data reached an all-time high of 0.130 Ratio in 2020 and a record low of 0.010 Ratio in 2004. United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United Arab Emirates – Table AE.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

Average number of cumulative new HIV infections and mean number of averted HIV infections among African American women over 20-year period by scenario.

Background: The Investment Framework Enhanced (IFE) proposed in 2013 by the Joint United Nations Programme on HIV/AIDS (UNAIDS) explored how maximizing existing interventions and adding emerging prevention options, including a vaccine, could further reduce new HIV infections and AIDS-related deaths in low- and middle-income countries (LMICs). This article describes additional modeling which looks more closely at the potential health impact and cost-effectiveness of AIDS vaccination in LMICs as part of UNAIDS IFE. Methods: An epidemiological model was used to explore the potential impact of AIDS vaccination in LMICs in combination with other interventions through 2070. Assumptions were based on perspectives from research, vaccination and public health experts, as well as observations from other HIV/AIDS interventions and vaccination programs. Sensitivity analyses varied vaccine efficacy, duration of protection, coverage, and cost. Results: If UNAIDS IFE goals were fully achieved, new annual HIV infections in LMICs would decline from 2.0 million in 2014 to 550,000 in 2070. A 70% efficacious vaccine introduced in 2027 with three doses, strong uptake and five years of protection would reduce annual new infections by 44% over the first decade, by 65% the first 25 years and by 78% to 122,000 in 2070. Vaccine impact would be much greater if the assumptions in UNAIDS IFE were not fully achieved. An AIDS vaccine would be cost-effective within a wide range of scenarios. Interpretation: Even a modestly effective vaccine could contribute strongly to a sustainable response to HIV/AIDS and be cost-effective, even with optimistic assumptions about other interventions. Higher efficacy would provide even greater impact and cost-effectiveness, and would support broader access. Vaccine efficacy and cost per regimen are critical in achieving cost-effectiveness, with cost per regimen being particularly critical in low-income countries and at lower efficacy levels.

This statistic depicts the total number of annual new HIV infections worldwide from 2000 to 2024. UNAIDS estimated that there were some *** million people worldwide that were newly infected with HIV in 2024. Total number of new HIV infections worldwideHuman immunodeficiency virus (HIV) is a condition that slowly destroys or impairs the body’s immune system. It is a retrovirus that slowly progresses through the various stages of the disease. As HIV reproduces, it mutates its structure, which makes it difficult to treat through drug therapy. Around **** million people were living with HIV worldwide as of 2024 with some **** million people accessing ART treatment. There are various types of ways to treat HIV. Antiviral treatment has been on the decline as combination therapy such as fixed-dose combinations become more popular. New HIV infections worldwide have been on the decline since 2000 from *** million new infections to *** million new infections in 2024. Many new infections occur in developing countries, especially those in low- and middle-income countries in Sub-Saharan Africa. Many of these individuals have no access to drugs or treatment that can make living with HIV more manageable. Children are also susceptible to infection, often from HIV-positive mothers during pregnancy, childbirth, or breastfeeding. There are approximately *** million children living with HIV globally.